Sylatron Trademark Details
Word Mark | Sylatron |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Serial Number | 78529555 |
---|---|
Status Date | Monday, June 8, 2009 |
Filing Date | Monday, June 8, 2009 |
Attorney | Nancy L. Rowe |
Correspondent
NANCY L. ROWE
SCHERING CORPORATION
2000 GALLOPING HILL ROAD
K-6-1 M1030
KENILWORTH NJ 07033-0530
SCHERING CORPORATION
2000 GALLOPING HILL ROAD
K-6-1 M1030
KENILWORTH NJ 07033-0530
Case File Statements
Goods & Services | Long-Acting Broad Spectrum Antiviral and Immunomodulating Agent |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Monday, December 20, 2004 |
Primary Code | 005 |
Trademark Timeline
-
Dec 09 2004Trademark application filed with USPTO
-
Dec 20 2004New Application Entered In Tram
-
Jul 14 2005Assigned To Examiner
-
Jul 18 2005Non-Final Action Mailed
-
Jul 18 2005Non-Final Action Written
-
Nov 23 2005Correspondence Received In Law Office
-
Nov 23 2005Teas Response To Office Action Received
-
Dec 07 2005Teas/email Correspondence Entered
-
Dec 08 2005Approved For Pub - Principal Register
-
Dec 09 2005Assigned To Lie
-
Dec 30 2005Law Office Publication Review Completed
-
Jan 25 2006Notice of Publication
-
Feb 14 2006Published For Opposition
-
May 09 2006Noa Mailed - Sou Required From Applicant
-
Nov 03 2006Extension 1 Filed
-
Nov 03 2006Teas Extension Received
-
Dec 19 2006Extension 1 Granted
-
May 03 2007Extension 2 Filed
-
May 03 2007Teas Extension Received
-
Aug 20 2007Extension 2 Granted
-
Oct 22 2007Extension 3 Filed
-
Oct 22 2007Teas Extension Received
-
Oct 26 2007Extension 3 Granted
-
Apr 28 2008Extension 4 Filed
-
Apr 28 2008Teas Extension Received
-
May 07 2008Extension 4 Granted
-
Oct 30 2008Extension 5 Filed
-
Oct 30 2008Teas Extension Received
-
Oct 31 2008Case Assigned To Intent To Use Paralegal
-
Nov 03 2008Extension 5 Granted
-
Jun 08 2009Abandonment Notice Mailed - No Use Statement Filed
-
Jun 08 2009Abandonment - No Use Statement Filed